T
here is broad consensus that public reporting of provider performance can be an important tool to drive improvements in patient care. In the United States, the Hospital Compare program, led by the Centers for Medicare & Medicaid Services (CMS) and others, reports hospitals' performance on a set of quality metrics for acute myocardial infarction (AMI), congestive heart failure (CHF), and pneumonia on a publicly accessible Web site. Hospital Compare initially reported process-of-care metrics only, but in 2008 it expanded to include 30-day mortality rates for these 3 conditions (1) . The goal of this program is to increase transparency for consumers and, in doing so, to encourage hospitals to improve their performance and, ultimately, achieve better clinical outcomes for their patients. Many other public reporting programs, modeled after Hospital Compare, report processes, outcomes, or both online before moving to a pay-for-performance phase. These programs include Dialysis Compare, Nursing Home Compare, and Physician Compare. New conditions are frequently added to these reporting programs.
Although the idea that public reporting could improve patient outcomes has strong face validity, there has been surprisingly little evidence that it has actually done so. Despite evidence that hospital performance on process metrics has improved substantially during the public reporting period, it is unclear whether patient outcomes have improved commensurately. A study by Ryan and colleagues found that, indeed, public reporting of processes of care on Hospital Compare was not associated with improved trends in mortality for the publicly reported conditions because most improvements for these conditions predated the initiation of reporting (2) . Advocates of public reporting countered that Ryan and colleagues examined a time period when hospitals were solely focused on public reporting of process measures and that improvements in clinical outcomes would follow when hospitals began to report them. However, whether public reporting of mortality led to lower mortality rates is as yet unknown.
Statistical Analysis
Hospital and patient characteristics are reported as percentages and, for age, as means. Because of significant seasonal variations, aggregate quarterly mortality rates were plotted after removal of the seasonal component using linear regression.
For our primary outcome, risk-adjusted 30-day mortality, we followed the CMS method used to calculate the mortality rates that are publicly reported on Hospital Compare (4 -7) . In accordance with CMS methods, we excluded patients discharged against medical advice and those enrolled in hospice services. We assigned medical comorbid conditions using the Hierarchical Condition Categories (HCCs) developed by CMS (8). We then created patient-level logistic regression models with hospital fixed effects to account for correlation over time and to allow time trends to be interpreted as within-hospital changes. The primary predictors in the model were linear time terms in the process-only reporting period (Q1 2005 through Q4 2007) and in the mortality-reporting period (Q1 2008 through Q4 2012) . The models were adjusted for patient age, sex, and HCCs so that temporal changes in patient composition would not mask time trends. Marginal standardization based on the total population of patients was used to estimate the mortality rate at the start and end of each reporting period (9). The logistic regression model coefficients were used to calculate the predicted probability of death for each patient, with all of their observed covariates, except for the time terms being set to the appropriate reporting quarter. These individual probabilities, when averaged together, represent a standardized mortality rate that can be compared across time.
We then calculated the average change in mortality over the time period by subtracting the estimated initial rate from the estimated final rate and dividing by the number of quarters in the time period. Approximate test-based CIs were based on an estimated SE for the difference in mortality rate change, calculated from the logistic regression test statistic for the change in the time trend. Please see the Appendix (available at www.annals.org) for a full explanation of model specifications.
These logistic regression models were initially constructed with both a change in intercept and a change in trend, but we found that the change in intercept was small (0.2%) and did not alter our trend estimates. Thus, we removed it from our models for ease of presentation. In sensitivity analyses, we used alternative cut points: 1 year earlier to address concerns that hospitals knew that mortality reporting was on the horizon and 1 quarter later to address concerns that hospitals would not react immediately to a policy change.
In our primary analysis, we built regression models to examine trends in mortality in the process-only reporting period and process and mortality reporting period for each of the publicly reported conditions. We then combined these conditions into a single model run across all hospitalizations for reported conditions, including an indicator for primary diagnosis, and we examined trends in the process-only reporting period and process and mortality reporting period using identical methods. We repeated each of these steps for the nonreported conditions, building patient-level regression models with hospital fixed effects to examine trends in mortality in both periods for each of the nonreported conditions individually, as well as for these conditions as a group. We then ran a model with all reported and nonreported conditions and included indicators for primary diagnoses as well as an indicator for whether the condition was reported or nonreported. This model also included an interaction term between the reporting indicator and the posttrend, which allowed us to test whether the change in ORIGINAL RESEARCH Public Reporting of Mortality Rates trends differed between reported and nonreported conditions.
To determine whether the relationship between public reporting and outcomes varied across distinct groups of hospitals, we conducted a set of prespecified subgroup analyses based on hospital characteristics. We hypothesized, for instance, that larger or teaching hospitals, or hospitals in more competitive markets, might be more sensitive to negative reputational effects of having high mortality rates, or, conversely, small, rural hospitals or those in less competitive markets may respond differently because patients have fewer alternatives. Therefore, we chose, a priori, to examine groups on the basis of hospital size, teaching status, urban versus rural location, ownership, and market competition (using the Hirschman-Herfindahl index). Each model accounted for the other characteristics of interest. Finally, we identified hospitals noted as negative outliers in the first publicly released performance report for mortality for each condition. The Centers for Medicare & Medicaid Services considers hospitals to be "worse than national rate" if they have at least 25 beneficiaries in the measure period and if the entire 95% interval estimate for their performance is above the national observed rate for that measure; this designation is posted on Hospital Compare (10). We examined each of these "worse than" outlier groups independently, as well as all outlier hospitals from the first report in aggregate. For the purposes of comparison, we also estimated the group of hospitals that would have been "worse than" outliers on the first report if the other conditions had been reported (that is, those for which the entire 95% CI of their estimated mortality rate from the regression model was above the national average mortality rate).
As a validation of our methods, we compared our calculated rates for the publicly reported conditions to those that were actually publicly reported by CMS on the Hospital Compare Web site. Because this Web site did not report mortality rates during the process reporting phase, we used the technical reports released by CMS in their measure construction to approximate rates in 2005 to 2007 (4 -6) . Because our data are calculated quarterly whereas CMS reports data on a 12-quarter rolling average, we compiled our quarterly data into rolling average rates to more closely match the CMS method for this comparison. These trends were similar and are shown in the Appendix Figure ( available at www.annals.org).
A 2-sided P value less than 0.05 was considered to represent a statistically significant difference. All analyses were performed using SAS software, version 9.2 (SAS Institute Inc.). This study was approved by the Harvard School of Public Health Office of Human Research Administration; the requirement for informed consent was waived because of the observational nature of the study and its use of deidentified data.
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RESULTS

Hospital and Patient Characteristics
Our sample included 3970 hospitals, representing roughly 85% of U.S. acute care hospitals; the hospitals not reporting were a combination of predominantly small, rural hospitals that are not required to do so because of small sample size and specialty hospitals to which the mortality metrics do not apply ( Table 1) . Nearly two thirds of participating hospitals were nonprofit, and 22% were public. Forty-three percent of hospitals in our sample were small, 46% were mediumsized, and 11% were large. Only 6.8% were major teaching hospitals, and nearly 80% were in an urban location. The hospitals were distributed across the United States, with 14% located in the Northeast, 30% in the Midwest, 39% in the South, and 17% in the West.
Across our selected conditions, these hospitals cared for 20 707 266 patients during our study period, ranging from 1 278 495 patients for renal failure to 2 892 085 for CHF (see Appendix Table 2 , available at www.annals.org, for condition-specific n values). Mean age in the overall sample was 79 to 80 years, and roughly 41% of patients were male ( Table 2 ). The 15 most common comorbidities, as assessed by the HCCs, Table 2 ; CHF, arrhythmia, renal failure, and chronic obstructive pulmonary disease were the most common. The prevalence of most comorbid conditions was higher during process and mortality reporting than during process-only reporting (see Appendix  Table 3 , available at www.annals.org, for year-by-year comorbidity prevalence).
Trends in Risk-Adjusted 30-Day Mortality Rates for Reported Conditions
When we plotted 30-day mortality rates for reported and nonreported conditions over time, we saw a continuous decrease in mortality rates during the study period, with no obvious improvement at the point of onset of mortality reporting ( Figure 1 ). When we formally examined trends in mortality for the 3 publicly reported conditions, we found that in aggregate, these conditions were improving at an absolute rate of Ϫ0.23% per quarter during the process-only reporting period. After the addition of public reporting of mortality rates in early 2008, this slowed to Ϫ0.09% per quarter (change, 0.13% per quarter; 95% CI, 0.12% to 0.14%) ( Table 3) .
We found that none of the individual conditions were improving faster in the process and mortality reporting period compared with the process-only reporting period. For AMI, mortality changed at a rate of Ϫ0.28% per quarter during process-only reporting and slowed to a change of Ϫ0.13% per quarter during process and mortality reporting (net change, 0.15% per quarter; CI, 0.12% to 0.18%); similarly, for CHF, the mortality rate was changing at a rate of Ϫ0.21% per quarter during process-only reporting, a rate that slowed to Ϫ0.06% per quarter during process and mortality reporting (change, 0.15% per quarter; CI, 0.13% to 0.16%). For pneumonia, mortality was changing at a rate of Ϫ0.21% per quarter during process-only report- ing, and this rate slowed to Ϫ0.10% per quarter during process and mortality reporting (change, 0.11% per quarter; CI, 0.09% to 0.13%) ( Table 3) .
When we examined the nonreported conditions, we found that changes in mortality were similar. Mortality was changing during process-only reporting at Ϫ0.17% per quarter, but the rate slowed during process and mortality reporting to Ϫ0.11% per quarter (change, 0.06% per quarter; CI, 0.05% to 0.07%). Among the individual conditions, we found that trends in mortality were unchanged or worse in the process and mortality reporting period than in the process-only reporting period for all the study conditions, with the exception of esophageal/gastric disease ( Table 3) . A formal test for differences in the change in trend between reported and nonreported conditions was statistically significant (difference in change in trend, 0.07% per quarter; CI, 0.068% to 0.072%).
Findings from our main analysis were similar when we included patients who had respiratory failure or sepsis with a secondary diagnosis of pneumonia in our cohort (Appendix Table 4 , available at www.annals .org). Results were unchanged after adjustment for race and ethnicity and urban versus rural status (Appendix Table 5 , available at www.annals.org). When we varied the date of initiation of reporting to 1 year earlier, the decrease in improvement was greater (0.19% per quarter; Appendix Table 6 , available at www.annals.org), and when we varied it to 1 quarter later, the decrease in improvement was similar (0.12% per quarter; Appendix Table 7 , available at www.annals.org).
Hospital Subgroups and Changes in Mortality Rates
When we examined subsets of hospitals that we thought might respond differentially to public reporting, we found no groups of hospitals based on hospital characteristics in which overall mortality rates appeared to improve after the implementation of process and mortality reporting compared with process-only reporting ( Figure 2) . Improvements in mortality seemed to slow less for small and rural hospitals than for their larger or more urban counterparts.
We did find that hospitals identified as outliers for any of the 3 conditions in the first mortality report tended to improve their mortality rates for that specific condition during the outcomes reporting period compared with the process reporting period (change, Ϫ0.05% per quarter for AMI [CI, Ϫ0.14% to 0.03%], Ϫ0.04% per quarter for CHF [CI, Ϫ0.08% to 0.00%], and Ϫ0.08% per quarter for pneumonia [CI, Ϫ0.12% to Ϫ0.04%]) (Figure 2) . However, these patterns were mirrored when we examined the group of hospitals that were poor performers at baseline on the nonreported conditions as well. The number of hospitals for which trends in mortality improved versus worsened is summarized in Appendix Table 8 (available at www .annals.org); overall, more hospitals improved than worsened, although the differences were small (51% versus 49% overall).
DISCUSSION
Public reporting of hospital mortality rates on Hospital Compare for Medicare patients with AMI, CHF, and pneumonia was associated with less of a decline in 30-day mortality rates after implementation than that seen in Medicare patients with conditions not subject to reporting. However, absolute mortality rates continued to decrease throughout the study period for all conditions studied.
We are unsure why public reporting of mortality rates has not accelerated overall improvements in this outcome for reported conditions in U.S. hospitals. One would surmise that public reporting ought to work Public Reporting of Mortality Rates ORIGINAL RESEARCH through a "peer-pressure" scenario, in which hospital leaders' knowledge that their performance will be publicly viewable by their peer institutions would motivate them to improve outcomes. One possible explanation for a lack of effect of public reporting in the overall sample is that the manner in which CMS calculates and displays mortality results may dilute this peer-pressure effect. CMS displays performance rating for hospitals in 3 major categories (worse than the national average, no different than the national average, and better than the national average), with only 2% to 3% of hospitals being rated as being worse than expected on any condition in any given year (10). Because most hospitals are thus labeled as average (or, very occasionally, above average), there may be little motivation for hospital leaders to invest the substantial resources and energy needed to improve patient outcomes. We found that for institutions identified in public reports as poor performers for pneumonia, evidence suggested condition-specific improvement in mortality trends after the onset of reporting. However, these trends were mirrored for hospitals that were poor performers on the nonreporting conditions; thus, it may be poor performance with regression to the mean, rather than the reporting itself, that was associated with a faster rate of improvement. It is possible that a reporting scheme that identified more hospitals as outliers, or one that provided a range of performance ratings (for example, much below average, below average, average, above average, and much above average), might have a larger effect overall.
Small and rural hospitals did seem to experience less of a slowing in improvement than their larger or more urban counterparts; because these were the hospital groups that were improving least rapidly in the prereporting period, this essentially led to an equalization in improvement rates with their larger and urban counterparts after the onset of reporting. It is possible that we saw a slowing of improvements in mortality rates overall because hospitals are reaching a lower limit of what is achievable; however, because some hospitals can still achieve mortality rates much below average, this seems less likely.
It is also possible that public reporting did not have a major effect on mortality rates overall because hospital leaders are not convinced that their peers or other 
Change From Process-Only to Process and Outcomes Reporting, % per quarter
B. Change in mortality trends for hospitals identified as negative outliers (poor performers) at baseline
A. Hospital characteristics. Markers to the right of the vertical rule represent groups in which the rate of improvement in mortality slowed during outcomes reporting. Markers to the left represent groups in which the rate of improvement in mortality increased during outcomes reporting. B. Outlier status. Each group comprises the hospitals that were the negative outliers (that is, the worst performers) during the baseline period. The numbers in parentheses indicate the number of hospitals identified as outliers in each group. For reported conditions, this was identified by hospitals that were negative outliers on Hospital Compare. For the nonreported conditions, we calculated "outlier status" using a similar method to identify the group of hospitals that would have been labeled as outliers if these conditions were being reported. Markers to the right of the vertical rule represent groups in which the rate of improvement in mortality slowed during outcomes reporting. Markers to the left represent groups in which the rate of improvement in mortality increased during outcomes reporting. AMI = acute myocardial infarction; CHF = congestive heart failure; GI = gastrointestinal.
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important stakeholders will see their data or hold them accountable. Given prior data showing that consumers rarely use publicly reported quality and outcomes information (11, 12), health care leaders may have been unconcerned that poor performance would lead to a loss in market share. Our study has limitations. We used administrative data, which may be limited in its ability to account for differences in severity of illness between hospitals and across time. It may be that the "sickness" profile of inpatients continues to rise in ways that we could not adequately take into account by using current riskadjustment models. However, one would have to posit that hospitals were progressively less likely to code comorbid condition in order for unmeasured severity over time to account for our inability to find a benefit of reporting; we did not see this pattern in our patient characteristics data, and a decrease in coding over time seems unlikely given intense financial pressures to code an increasing number of comorbid conditions. We did not have access to sociodemographic data, such as education, income, and housing, that might affect patient outcomes. Probably because the 3 publicly reported conditions have been the subject of attention for many years, we did not have a control group with a pretrend identical to that in our intervention group. We included only hospitals that were reporting as of the first year of mortality reporting in our sample in order to test the intervention in as clean a manner as possible; our findings may not apply to hospitals that have newly opened since 2009. Finally, improving a hard outcome, such as 30-day mortality, may take longer than the 5 years of outcomes reporting data we included in this study. Whether benefits accrue over a longer period is unclear and requires further evaluation.
Our study adds to a growing body of literature on public reporting, both at the condition level (that is, AMI, CHF, and pneumonia) and at the procedural level (predominantly coronary artery bypass grafting, coronary artery bypass grafting, and percutaneous coronary intervention). Previous studies on Hospital Compare have been somewhat mixed; early studies of the process reporting program demonstrated an association between improvement in processes of care and improvement in mortality rates (13-15), although follow-up studies showed that mortality trends overall were unchanged after public reporting of processes alone (2) . Therefore, the hypothesis that we did not find an effect because process reporting alone captured most of the benefit of public reporting is unlikely. Similarly, although early studies of coronary artery bypass grafting reporting demonstrated a reduction in mortality rates (16 -18), more recent studies of reporting of coronary artery bypass grafting and percutaneous coronary intervention have failed to find a benefit of reporting (19 -21) and have demonstrated potential adverse effects, such as reduced access to percutaneous coronary intervention in the setting of AMI (19, 22) . Hospital Compare's switch from reporting only processes of care to also reporting 30-day mortality rates for common medical conditions was not associated with significant improvements in mortality rates for reported conditions in U.S. hospitals. Although CMS is increasingly moving toward pay-for-performance as a quality improvement strategy, public reporting remains a mainstay of its efforts as it moves into outcomes measurement across additional conditions in the hospital. as well as the postacute, provider, and practice settings, and typically predates pay-for-performance by 2 to 3 years. Our findings suggest that expectations for performance improvement from reporting alone should remain limited. 
APPENDIX: DETAILED METHODS
Model Specifications
For our analyses, we used fixed-effects logistic regression models to look for trends over time after adjusting for patient age, sex, and HCC comorbid conditions. Logistic regression was used because our outcome was binary (dead/alive) and the binomial specification with the logit link assures us that the appropriate binomial likelihood will be used, that predicted probabilities will be in the correct range of [0, 1] , and that heterogeneity of variance will be accounted for. Fixed effects for hospitals were included in the model to account for correlation within hospital over time. Inclusion of fixed effects also ensures that the time effects reflect purely within-hospital changes in mortality over time. Otherwise, changes in mortality could be artifacts of changes in the sample of hospitals available at any given month (that is, if poor-quality hospitals closed over time, then mortality rates would appear to decrease even if there were no real changes within hospitals).The model included patient characteristics to ensure that changes in patient severity over time did not mask true changes in the probability of death due to the quality of care provided by a hospital (that is, if patients became sicker over time, mortality rates would appear to increase over time, even if a hospital's quality of care did not change). Thus, our model specification was as follows: Log-odds (30-day death) = ␣ 1 hospital + ␤ 1 age + ␤ 2 sex + ␤ 3 HCC variables + 
Estimating Mortality Rates and Quarterly Changes in Mortality
Marginal standardization based on the total population of patients in the study database was used to estimate the mortality rate at the start and end of each reporting period: Q1 2005, Q4 2007, Q1 2008, and Q4 2012 . The logistic regression model coefficients were used to calculate the predicted probability of death for each individual patient, with all of their observed covariates, except for the time terms being set to the prechosen reporting quarter.
For example, to estimate the mortality rate for a patient during Q1 2005, we have:
"time in quarters" = 1 and "time2 in quarters" = 0 We then calculated the average quarterly change in mortality over the pre-and postreporting period by subtracting the estimated initial rate from the estimated final rate and dividing by the number of quarters in the time period.
[ 430, 431, 4320, 4321, 4329, 43301, 43311, 43321, 43331, 43381, 43391, 43401, 43411, 43491 Sepsis 0031, 0362, 0363, 03689, 0369, 0380, 03810, 03811, 03819, 0382, 0383, 03840, 03841, 03842, 03843, 03844, 03849, 0388, 0389, 0545, 78552, 78559, 7907, 99590, 99591, 99592, 99593, 99594 Esophagitis and gastroenteritis 0030, 0040, 0041, 0042, 0043, 0048, 0049, 0050, 0053, 0054, 581, 589, 0059, 0060, 0061, 062, 0071, 0074, 0078, 00800, 00801, 00802, 00804, 00809, 0082, 0083, 00841, 00842, 00843, 00844, 00845, 00846, 00847, 00849, 0085, 00861, 00862, 00863, 00867, 00869, 0088, 0090, 0091, 0092, 0093, 11284, 11285, 1231 , 1269 , 1271 , 1272 , 1273 , 1279 , 129, 22804, 2712 , 2713 , 5789 Urinary tract infection 01600, 01634, 03284, 1200 , 59000, 59010, 59011, 5902, 5903, 59080, 5909, 5933, 5950, 5951, 5952, 5953, 59581, 59589, 5959, 5970, 59780, 59781, 59789, 5990 Nutritional or metabolic disorder 2510 , 2512 , 2513 , 260, 261, 262, 2630 , 2631 , 2638 , 2639 , 2651 , 2661 , 2662 , 2669 , 267, 2689 , 2690 , 2691 , 2692 , 2693 , 2698 , 2699 , 2752 , 27540, 27541, 27542, 27549, 2760 , 2761 , 2762 , 2763 , 2764 , 2765 , 27650, 27651, 27652, 2766 , 2767 , 2768 , 2769 , 27700, 27800, 27801, 27802, 2781 , 2783 , 2784 , 2788 AMI = acute myocardial infarction; CHF = congestive heart failure; ICD-9-CM = 
